Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BECTON DICKINSON & CO Director's Dealing 2024

Mar 5, 2024

30003_dirs_2024-03-05_39c8dbba-5bc9-4b96-aba3-7b59df43b7ff.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BECTON DICKINSON & CO (BDX)
CIK: 0000010795
Period of Report: 2024-03-01

Reporting Person: Garrison Michael David (EVP & President Medical)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-03-01 Common Stock F 178 $0.0 Disposed 7096 Direct

Footnotes

F1: Represents shares withheld for payment of withholding taxes in connection with vesting of restricted stock units previously reported on Table I.